|Articles|February 19, 2016
Translational Medicine: A “Team Sport”?
Author(s)DIA
February 19, 2016
Advertisement
Dr. Makoto Suematsu, President of the Japan Agency for Medical Research & Development (AMED); and Dr. Christopher P. Austin, Director of the National Center for Advancing Translational Sciences (NCATS), US National Institutes of Health; discuss how collaboration between their agencies will ultimately deliver better therapies more quickly to more patients.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
5
